We are live on ! Find out more
DGM

Darwin Global Management Portfolio holdings

AUM $3.77B
1-Year Est. Return 307.72%
This Fund
S&P 500
This Quarter Est. Return
+35.85%
1 Year Est. Return
+307.72%
3 Year Est. Return
+2,873.14%
5 Year Est. Return
+48,315.58%
10 Year Est. Return
AUM
$2.38B
AUM Growth
+$920M
Cap. Flow
+$354M
Cap. Flow %
14.86%
Top 10 Hldgs %
100%
Holding
5
New
2
Increased
3
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSM icon
1
Insmed
INSM
$23.5B
$1.92B 80.75%
19,344,621
+3,946,646
+26% +$302M
VRNA
2
DELISTED
Verona Pharma
VRNA
$387M 16.26%
4,129,618
+206,414
+5% +$15.3M
CDTX
3
DELISTED
Cidara Therapeutics
CDTX
$38M 1.59%
+768,424
New +$18.5M
MRUS
4
DELISTED
Merus
MRUS
$21M 0.88%
+395,738
New +$18.6M
ALLO icon
5
Allogene Therapeutics
ALLO
$618M
$12.4M 0.52%
10,479,791
+30,000
+0.3% +$39.9K

Similar funds

Darwin Global Management's Q2 2025 Portfolio in Review

As of Q2 2025, Darwin Global Management held 5 positions worth $2.38B, up 63% from $1.46B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Darwin Global Management deployed $354M of net new capital in Q2 2025, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was Merus: 395,738 shares worth $21M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Darwin Global Management's largest Q2 2025 buy was Merus: 395,738 shares worth $21M.
  • Darwin Global Management added most to Insmed in Q2 2025, an estimated $302M increase.
  • Darwin Global Management's ten largest holdings make up 100% of its $2.38B portfolio in Q2 2025.
  • Darwin Global Management opened 2 new positions and closed 0 in Q2 2025.
  • Darwin Global Management's portfolio value rose 63% quarter-over-quarter to $2.38B.

Based on Darwin Global Management's 13F filing for Q2 2025, filed 14 Aug 2025.